Browsing: Oncology

Summary On September 27, 2024, the FDA approved selpercatinib (Retevmo) for advanced or metastatic medullary thyroid cancer patients with a…

Summary   A study at Peking University Third Hospital focused on patients with locally advanced rectal cancer who underwent neoadjuvant…

Summary On September 25, 2024, the FDA approved osimertinib for adult patients with certain types of non-small cell lung cancer…

Summary   On September 20, 2024, the FDA approved isatuximab-irfc for adults with newly diagnosed multiple myeloma who are not…

Summary • Rybrevant (amivantamab-vmjw) was approved by the FDA for adults with non-small cell lung cancer who have EGFR mutations…

Summary Pembrolizumab (Keytruda) with pemetrexed and platinum chemotherapy was FDA-approved for treating advanced malignant pleural mesothelioma. The combination treatment showed…

Summary A study included 108 patients assessed gene expression in patients with prostate enlargement after receiving finasteride or doxazosin. Finasteride…

Summary A new study evaluated the sensitivity and specificity of a method in detecting ADNP mRNA expression in circulating tumor…

Summary Researchers conducted an experiment to explore the effect of boron treatment with radiation therapy for patients with prostate cancer.…

Summary Retrospective study included 126 patients with thymoma and 5 with thymic carcinoma, with data collected from 2015 to 2023.…